Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy
Clinical Colorectal Cancer · 2024
DOI: 10.1016/j.clcc.2023.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2024. Verfasst von Jacopo Giuliani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Azienda ULSS 9 Scaligera, Legnago (VR), Italy. Electronic address: jacopo.giuliani@aulss9.veneto.it. Hauptthemen laut MEDLINE: Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Pyrrolidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Azienda ULSS 9 Scaligera, Legnago (VR), Italy. Electronic address: jacopo.giuliani@aulss9.veneto.it.
- Department of Diagnostic Imaging, Azienda ULSS 9 Scaligera, Legnago (VR), Italy.
- Department of Oncology, Azienda ULSS 9 Scaligera, Legnago (VR), Italy.
- Pharmaceuthical Department, Azienda ULSS 9 Scaligera, Legnago (VR), Italy.
Zitieren
APA
Giuliani, J., Mantoan, B., Mangiola, D., Muraro, M., Napoli, G., Tommasi, M., Fiorica, F., & Mandarà, M. (2024). Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2023.10.005
Vancouver
Giuliani J, Mantoan B, Mangiola D, Muraro M, Napoli G, Tommasi M, et al. Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy. Clinical Colorectal Cancer. 2024. doi:10.1016/j.clcc.2023.10.005
BibTeX
@article{Giuliani2024,
author = {Giuliani, Jacopo and Mantoan, Beatrice and Mangiola, Daniela and Muraro, Marco and Napoli, Giuseppe and Tommasi, Marina and Fiorica, Francesco and Mandarà, Marta},
title = {Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy},
journal = {Clinical Colorectal Cancer},
year = {2024},
doi = {10.1016/j.clcc.2023.10.005}
}
EUVIMED